These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27463020)

  • 1. Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps.
    Zheng H; Ji J; Zhao L; Chen M; Shi A; Pan L; Huang Y; Zhang H; Dong B; Gao H
    Oncotarget; 2016 Sep; 7(37):59189-59198. PubMed ID: 27463020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
    Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y
    Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma.
    Gatto F; Blum KA; Hosseini SS; Ghanaat M; Kashan M; Maccari F; Galeotti F; Hsieh JJ; Volpi N; Hakimi AA; Nielsen J
    Eur Urol Oncol; 2018 Oct; 1(5):364-377. PubMed ID: 31158075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.
    Kubota S; Yoshida T; Kageyama S; Isono T; Yuasa T; Yonese J; Kushima R; Kawauchi A; Chano T
    World J Surg Oncol; 2020 Oct; 18(1):270. PubMed ID: 33092599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis.
    Gao H; Dong B; Liu X; Xuan H; Huang Y; Lin D
    Anal Chim Acta; 2008 Aug; 624(2):269-77. PubMed ID: 18706333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine metabolomic analysis in clear cell and papillary renal cell carcinoma: A pilot study.
    Oto J; Fernández-Pardo Á; Roca M; Plana E; Solmoirago MJ; Sánchez-González JV; Vera-Donoso CD; Martínez-Sarmiento M; España F; Navarro S; Medina P
    J Proteomics; 2020 Apr; 218():103723. PubMed ID: 32126320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up.
    Somani BK; Nabi G; Thorpe P; N'Dow J; Swami S; McClinton S;
    Eur Urol; 2007 May; 51(5):1289-95; discussion 1296-7. PubMed ID: 17081679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.
    Monteiro MS; Barros AS; Pinto J; Carvalho M; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Guedes de Pinho P
    Sci Rep; 2016 Nov; 6():37275. PubMed ID: 27857216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuron-specific enolase: a serum tumor marker in renal cell carcinoma?
    Gross AJ; Michl UH; Bornhöft G; Dieckmann KP
    Eur Urol; 1993; 24(3):397-9. PubMed ID: 8262110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of metabolomics-derived biomarkers to identify renal cell carcinoma: a comprehensive perspective of the past ten years and advancements.
    Gupta A; Nath K; Bansal N; Kumar M
    Expert Rev Mol Diagn; 2020 Jan; 20(1):5-18. PubMed ID: 31825678
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of ex vivo (1)H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases.
    Gao H; Dong B; Jia J; Zhu H; Diao C; Yan Z; Huang Y; Li X
    J Cancer Res Clin Oncol; 2012 May; 138(5):753-61. PubMed ID: 22258851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.
    Kim KH; Lee HH; Yoon YE; Na JC; Kim KS; Han WK
    Investig Clin Urol; 2019 Nov; 60(6):425-431. PubMed ID: 31692952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Footprinting of a Clear Cell Renal Cell Carcinoma in Vitro Model for Human Kidney Cancer Detection.
    Knott ME; Manzi M; Zabalegui N; Salazar MO; Puricelli LI; Monge ME
    J Proteome Res; 2018 Nov; 17(11):3877-3888. PubMed ID: 30260228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy.
    Nishikawa M; Miyake H; Harada K; Fujisawa M
    Urol Oncol; 2014 Jan; 32(1):49.e15-21. PubMed ID: 24239474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of renal cell carcinoma with vena cava tumor thrombi].
    Li XF; Zhou FJ; Qiu SP; Liu ZW; Wu RP; Huang K; Mei H
    Ai Zheng; 2004 Sep; 23(9):1074-6. PubMed ID: 15363205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative decision making for renal cell carcinoma: cystic morphology in cross-sectional imaging might predict lower malignant potential.
    Huber J; Winkler A; Jakobi H; Bruckner T; Roth W; Hallscheidt P; Daneshvar K; Hohenfellner M; Pahernik S
    Urol Oncol; 2014 Jan; 32(1):37.e1-6. PubMed ID: 23587431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radial nephrectomy for small renal cell carcinoma.
    Yu J; Zhang G; Liang P; Yu XL; Cheng ZG; Han ZY; Zhang X; Dong J; Li QY; Mu MJ; Li X
    Abdom Imaging; 2015 Oct; 40(8):3248-56. PubMed ID: 26288264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine metabolomics analysis for kidney cancer detection and biomarker discovery.
    Kim K; Aronov P; Zakharkin SO; Anderson D; Perroud B; Thompson IM; Weiss RH
    Mol Cell Proteomics; 2009 Mar; 8(3):558-70. PubMed ID: 19008263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implication of extrarenal metabolic tumor burden in advanced renal cell carcinoma treated with targeted therapy after nephrectomy.
    Yoon HJ; Paeng JC; Kwak C; Park YH; Kim TM; Lee SH; Chung JK; Edmund Kim E; Lee DS
    Ann Nucl Med; 2013 Oct; 27(8):748-55. PubMed ID: 23818007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.